Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac2c17e532220d91aca9a28ef60f178b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
filingDate |
2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_befbbdfaccfbbd9c9336aa8b2527b758 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6e1e526a59fba0cbb731ed6bbb455f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53c344249c7be0257680ed79569414c1 |
publicationDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1663229-A2 |
titleOfInvention |
Pharmaceutical combinations of hydrocodone and naltrexone |
abstract |
Disclosed is a pharmaceutical composition comprising from about 5 to about 20 mg of hydrocodone or a pharmaceutically acceptable salt thereof and from 0.055 to about 0.56 mg naltrexone or pharmaceutically acceptable salt thereof |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707184-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959958-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10172797-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195153-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10639281-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792254-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9492444-B2 |
priorityDate |
2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |